Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 1
1963 1
1964 2
1965 1
1967 1
1969 2
1970 2
1971 1
1972 7
1973 3
1974 4
1975 3
1976 4
1977 5
1978 7
1979 2
1980 4
1981 8
1982 4
1983 2
1984 5
1985 1
1986 8
1987 19
1988 9
1989 15
1990 11
1991 16
1992 25
1993 36
1994 30
1995 39
1996 49
1997 58
1998 75
1999 92
2000 100
2001 117
2002 142
2003 206
2004 235
2005 262
2006 275
2007 339
2008 428
2009 449
2010 603
2011 639
2012 734
2013 736
2014 791
2015 805
2016 791
2017 788
2018 777
2019 810
2020 779
2021 820
2022 753
2023 671
2024 690
2025 637
2026 411

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,625 results

Results by year

Filters applied: . Clear all
Page 1
Resting-state hemodynamic changes and effects on upper limb function after multi-channel transcranial direct current stimulation to the ipsilesional primary motor cortex and anterior intraparietal sulcus in stroke patients: an fNIRS pilot study.
Lee SH, Lee G, Kim J, Phillips V Z, Kim H, Kim E, Lee SH, Jeong HC, Paik SH, Kim YH, Kim BM. Lee SH, et al. Among authors: kim yh. J Neuroeng Rehabil. 2025 Apr 16;22(1):83. doi: 10.1186/s12984-025-01618-8. J Neuroeng Rehabil. 2025. PMID: 40241110 Free PMC article. Clinical Trial.
Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM).
Lee EK, Kim MJ, Hwangbo Y, Moon JH, Cho SW, Chai YJ, Choi JY, Jung YS, Lee KE, Chung EJ, Kim K, Kim SJ, Kim W, Kim YH, Lee YK, Jang J, Song YS, Yi KH, Yu HW, Moon S, Jung KY, Kim HJ, Ryu CH, Ryu J, Seok J, Kang SH, Lee S, Chu AJ, Lee CY, Lee JY, Lim H, Kim JH, Park SK, Park YJ. Lee EK, et al. Among authors: kim yh. J Korean Med Sci. 2026 Jan 26;41(4):e58. doi: 10.3346/jkms.2026.41.e58. J Korean Med Sci. 2026. PMID: 41589080 Free PMC article.
Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial.
Ki YJ, Kim W, Lee KH, Han SJ, Kim YH, Doh JH, Kim TN, Chung CH, Kim DY, Cho JM, Yoon HJ, Jeong IK, Park S, Song KH, Yu CW, Cho DK, Choi SH, Oh SJ, Shin S, Jeong H, Park Y, Kim HS. Ki YJ, et al. Among authors: kim yh. Clin Cardiol. 2025 May;48(5):e70138. doi: 10.1002/clc.70138. Clin Cardiol. 2025. PMID: 40357888 Free PMC article. Clinical Trial.
Small heterodimer partner protects against osteoarthritis by inhibiting IKKβ/NF-κB-mediated matrix-degrading enzymes in chondrocytes.
Kang EJ, Noh JR, Kim JH, Park JA, Ahn JP, Kim MC, Choi JH, Choi YK, Lee IB, Choi DH, Seo YJ, Jung YS, Kim KS, Hwang JH, Kim YB, Lee JS, Ku BJ, Jeong JO, Choi HS, Kim J, Kim YH, Lee CH. Kang EJ, et al. Among authors: kim yh. Nat Commun. 2026 Feb 21;17(1):4270. doi: 10.1038/s41467-026-69864-5. Nat Commun. 2026. PMID: 41723166 Free PMC article.
Mechanoimmunological Control of Metastatic Site Selection.
Elbanna YA, Tello-Lafoz M, Holland A, Zhang Y, Kwak JG, Wang Z, Yakimov A, Dada M, Vayner S, Duquette SM, Kim YH, Bale TA, Winer BY, Yu KKH, Massagué J, Lee J, Barzilai O, Manalis SR, Huse M. Elbanna YA, et al. Among authors: kim yh. bioRxiv [Preprint]. 2025 May 13:2025.05.10.653256. doi: 10.1101/2025.05.10.653256. bioRxiv. 2025. PMID: 40462959 Free PMC article. Preprint.
Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity.
Panda AK, Natarajan K, Sinha S, Jiang J, Chempati S, Boyd LF, Desai PP, Buszko M, Kim YH, Kazmi S, Fisk B, Teke ME, Larrain CM, Remmert K, Blakely AM, Douagi I, Hernandez JM, Margulies DH, Shevach EM. Panda AK, et al. Among authors: kim yh. Cancer Immunol Res. 2025 Dec 2;13(12):1938-1955. doi: 10.1158/2326-6066.CIR-25-0343. Cancer Immunol Res. 2025. PMID: 41032026 Free PMC article.
13,625 results
You have reached the last available page of results. Please see the User Guide for more information.